Our goal is to develop antibody-based medications for stimulant abuse, which alter the pharmacokinetic properties of these drugs. These studies are part of a multidisciplinary, clinician scientist approach to the rational development of therapeutic strategies, and provide the background information necessary for translational research of the efficacy of antibody-based medications for the treatment of human […]
Betholyn Gentry
Liz Gates
Edgar Garcia-Rill, Ph.D.
Jay Gandy, Ph.D.
Brendan Frett, Ph.D.
Dr. Frett’s research is focused on small molecule drug design and developing enabling chemical methodologies to expedite the drug discovery process. In particular, he is interested in identifying single-agent therapies capable of controlling multiple, dysregulated pathways in cancer.
Clifford Franklin, Ph.D.
James Craig Forrest, Ph.D.
Virology, cancer biology, immunology! Gammaherpesviruses are cancer-causing viruses that infect the majority of humans. We are working to define functions of viral proteins in infection and disease, identify host factors that block viral infection and prevent virus-driven cancers, and understand immune responses to chronic viral infections. Our major goal is to comprehend the complex relationship […]